Iranian drugmaker opens $100M plant in Turkey, will make Humira biosimilar

Turkey is getting its first locally produced mAb via an Iranian biosimilars marker and the $100 million plant it built there.

CinnaGen Pharmaceuticals has opened the plant in Çerkezköy, in northwestern Turkey's Tekirdağ, the Daily Sabah reports.